The largest database of trusted experimental protocols

Fitc labeled dextran

Manufactured by Merck Group
Sourced in United States, Germany

FITC-labeled dextran is a fluorescent marker used in laboratory experiments. It consists of dextran, a polysaccharide, conjugated with fluorescein isothiocyanate (FITC), a fluorescent dye. This product can be used to track the movement and distribution of molecules or cells in various biological systems.

Automatically generated - may contain errors

109 protocols using fitc labeled dextran

1

Actin Polymerization and Permeability Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unlabeled poly-l-lysine
(molecular weight (MW) 15–30 kDa)
and fluorescently labeled FITC-poly-l-lysine (MW 15–-30 kDa) were purchased from Sigma-Aldrich.
Individual nucleotides (ATP and GTP) were purchased from Thermo Scientific.
Cy5-labeled polylysine (MW 25 kDa) was
purchased from Nanocs Inc. Actin (rabbit skeletal muscle α actin),
fluorescently labeled ATT0 532-actin (rabbit skeletal muscle α
actin), and ATT0 594-actin were purchased from HYPERMOL in the form
of lyophilized powders. The composition of the reconstitution buffer
to dissolve actin monomers was 2 mM Tris (pH 8.0), 0.4 mM ATP, 0.1
mM CaCl2, and 0.01 mM dithiothereitol. The end composition
of the actin polymerization buffer was 0.01 M imidazole pH 7.4, 0.1
M KCl, and 2 mM MgCl2. Fluorescently labeled ATTO-594-phalloidin
was purchased from HYPERMOL (Cat. No. C8815-01). For permeability
experiments, we used various FITC-labeled dextran solutions: MW 3–5 kDa (Sigma, Cat. No. FD4; mol FITC/mol
glucose = 0.001–0.02), FITC-labeled dextran MW 20
kDa (Sigma, Cat. No. FD20S; mol FITC/mol glucose = 0.003-0.02), FITC-labeled
dextran MW 70 kDa (Sigma, Cat. No. 46945;
mol FITC/mol glucose = 0.004), and FITC-labeled dextran MW 150 kDa (Sigma, Cat. No. 46946; mol FITC/mol glucose
= 0.004) to actinosome. Polyvinyl alcohol (PVA), molecular weight
30,000–70,000, 87–90% hydrolyzed, was purchased from
Sigma-Aldrich.
+ Open protocol
+ Expand
2

Intestinal Barrier Permeability Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to measure intestinal barrier permeability, rats were gavaged with a permeability tracer, FITC-labeled dextran (6 mg/100 g body weight of FITC-labeled dextran, mol wt. 4,000; Sigma-Aldrich, St. Louis, MO, USA) on day 3. While food and water were withdrawn 4 hours before the gavage. Four hours after gavage, blood was withdrawn by cardiac puncture 4 hours after the gavage. Fluorescence intensity of the serum samples was measured using a Victor 3 spectrophotometer (excitation 490 nm, emission 525 nm, Cytofluor 2300; PerkinElmer, Waltham, MA, USA; Waters Chromatography). The FITC-dextran concentrations were determined from standard curves generated by serial dilution of FITC-dextran. Permeability was calculated by the linear regression of sample fluorescence.14 (link)
+ Open protocol
+ Expand
3

Matrigel Barrier Permeability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
We designed an additional degradation model that better captured the complexity of the basement membrane, based on a tissue penetration model described by Andrian et al. (85 (link)). Matrigel (Corning) was diluted 1:3 in cold PBS, and 100 μL were added to 0.4 μm polycarbonate trans-well plate inserts (VWR). The Transwell plates were placed in a temperature of 4°C for 30 min to let the Matrigel settle, and they were then moved to an anaerobic chamber to gel at 37°C for 24 h. The next day, the Matrigel was rehydrated in 100 μL of sterile reduced PBS for 1 h at 37°C. In the meantime, a 10 mg/mL stock of 40 kDa FITC-labeled dextran (Millipore Sigma) was prepared and later diluted in either media or supernatant at a final concentration of 0.5 mg/mL. 150 μL of the supernatant containing FITC-labeled dextran was pipetted on top of the Matrigel, and 300 μL of PBS were added to the lower chamber. The Transwell plates were then incubated anaerobically for 24 h at 37°C. Fluorescence in the bottom chamber was measured to assess the permeability of the Matrigel layer. Because dextran is a carbohydrate that could be digested by gut bacteria, the percentage of dextran that successfully traversed the membrane was calculated in comparison to the fluorescence levels in the leftover FITC-dextran and supernatant solution after the same anaerobic incubation at 37°C.
+ Open protocol
+ Expand
4

Angiogenesis Assessment of CGAG Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following stereomicroscopy, 0.1 mL of the blood plasma marker 5% FITC-labeled dextran (150,000 Da; Sigma-Aldrich) was retrobulbarily injected into the venous plexus of the anesthetized animals for contrast enhancement. The observation window of the chamber was positioned under a Zeiss Axiotech microscope (Zeiss, Oberkochen, Germany) and the microscopic images were recorded by a charge-coupled device video camera (FK6990; Pieper, Schwerte, Germany) and a DVD system for off-line analyses by means of CapImage [21 (link)].
The vascularization of implanted CGAG scaffolds was assessed in 12 regions of interest (ROIs). ROIs exhibiting red blood cell (RBC)-perfused microvessels were defined and counted as perfused ROIs (in % of all ROIs) [6 (link), 8 (link)]. Furthermore, the functional microvessel density (FMD) was determined as the total length of all RBC-perfused microvessels per ROI (given in cm/cm2). In addition, the diameter (d, given in µm) and centerline RBC velocity (v, given in µm/s) of 40 randomly selected microvessels were measured. Subsequently, these two parameters were used to calculate the wall shear rate (y, given in s−1) by means of the Newtonian definition y = 8 × v/d [6 (link), 8 (link)].
+ Open protocol
+ Expand
5

Quantifying Microvascular Perfusion in Tissue Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following stereomicroscopy, 0.1 mL of the blood plasma marker 5% FITC-labeled dextran (150,000 Da; Sigma-Aldrich) was retrobulbarily injected into the venous plexus of the anesthetized animals for contrast enhancement. The observation window of the chamber was positioned under a Zeiss Axiotech microscope (Zeiss, Oberkochen, Germany) and the microscopic images were recorded by a charge-coupled device video camera (FK6990; Pieper, Schwerte, Germany) and a DVD system for off-line analyses by means of CapImage (Karschnia et al., 2018 (link)).
The vascularization of implanted CGAG matrices was assessed in 12 regions of interest (ROIs). ROIs exhibiting red blood cell (RBC)-perfused microvessels were defined and counted as perfused ROIs (in % of all ROIs) (Später et al., 2017a (link); Später et al., 2017b (link)). Furthermore, the functional microvessel density (FMD) was determined as the total length of all RBC-perfused microvessels per ROI (given in cm/cm2). In addition, the diameter (d, given in µm) and centerline RBC velocity (v, given in µm/s) of 40 randomly selected microvessels were measured. Subsequently, these two parameters were used to calculate the wall shear rate (y, given in s−1) by means of the Newtonian definition y = 8 x v/d.
+ Open protocol
+ Expand
6

Visualizing Tumor Microvasculature

Check if the same lab product or an alternative is used in the 5 most similar protocols
On study day 30, the mice were anesthetized with sodium pentobarbital (50 mg/kg bw, i.p). Fluorescence tracers (0.1 mL of 0.5% fluorescein isothiocyanate- (FITC-) labeled dextran (MW = 200,000, Sigma Chemical, USA)) were injected in the jugular vein. The tumor microvasculature was visualized under confocal microscope.
+ Open protocol
+ Expand
7

Transwell Barrier Integrity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCMEC/D3 cells were grown on 0.4 μm transwell inserts (Merck Millipore Corporation, Billerica, MA, USA) as per the manufacturer’s instructions. After the cells grew to confluence, they were exposed to 125 ng/mL nSLY or corresponding bacterial strain culture supernatants for 4 h, and at the same time, the FITC-labeled dextran (10 kDa, 100 μg/mL, Sigma, Tokyo, Japan) was added to the upper compartment and incubated together. The amount of FITC-dextran that crossed the filter to the basolateral compartment was measured with a SpectraMax® i3 (Molecular Devices, San Jose, CA, USA).
+ Open protocol
+ Expand
8

Intestinal Permeability Assay in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intestinal epithelial barrier permeability was tested using a permeability tracer (FITC-labeled dextran) as described previously (Di Sabatino et al., 2012 (link)). Briefly, the mice were maintained fasted and deprived of water overnight, and FITC-labeled dextran (Sigma-Aldrich, Saint Louis, MO, United States) was then administered to each mouse intragastrically at a dose of 44 mg/100 g body weight. Four hours later, the mouse blood was drawn, and serum was reserved for measurement of the fluorescence intensity, which was obtained by reading the absorbance at 525 nm with a Spark multimode microplate reader (TECAN, Switzerland). The fluorescence intensity of each sample was then calculated according to a standard curve ranging from 2,000 to 100 μg/ml (Zhang and Li, 2014 (link)).
+ Open protocol
+ Expand
9

In vivo Gut Permeability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo gut permeability assay was performed as described previously53 (link). Briefly, mice were fed 0.6 mg/g FITC-labeled dextran (Sigma) after fasting for 5 hrs. Serum samples were collected at indicated time points and analyzed (485 nm/535 nm) using a microplate reader (Tecan Infinite M100 pro).
+ Open protocol
+ Expand
10

Quantifying Choroidal Neovascularization in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anesthetized mice were perfused through the left ventricle with PBS followed by 5 mg/ml fluorescein isothiocyanate (FITC)-labeled dextran (MW=10,000 Da; Sigma, St. Louis, MO). The eyes were enucleated and fixed in a 4% paraformaldehyde solution. The anterior segment and retina were removed from the eyecup, and the remaining RPE/choroid/sclera complexes were flatmounted after four radial incisions. The dissected RPE/choroid/sclera were treated with blocking solution (5% BSA, 5% normal donkey serum, and 0.5% Triton X-100 in PBS) for 1 h at room temperature and incubated with Alexa Fluor® 594-conjugated Griffonia simplicifolia isolectin B4 (1:100 dilution; Invitrogen) overnight at 4 °C. The samples were washed three times with PBS and mounted sclera side down on microscope slides. Images of CNV lesions were obtained using a fluorescence microscope (Olympus), and the CNV area in each image was calculated using ImageJ software (NIH). For the analysis of CNV volumes, Z-stack images of CNV lesions were acquired with an LSM780 confocal microscope (Zeiss, Jena, Germany). The sum of the CNV area in each Z-stack layer (multiplied by 5-μm thickness) was used as the volume of the CNV lesion [11 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!